Navigation Links
ZRT Laboratory Launches Serum Test for Brain-Derived Neurotrophic Factor (BDNF)

ZRT Laboratory is pleased to announce the commercial launch of Brain-Derived Neurotrophic Factor (BDNF) testing in serum. BDNF plays a vital role in protecting existing neurons in the central and peripheral nervous systems. BDNF stimulates the growth and differentiation of new neurons in the brain involved in learning, memory, and higher thinking. Low serum levels of BDNF have been linked with neurodegenerative autoimmune diseases such as multiple sclerosis and diseases of the central nervous system including major depression, bipolar disorder, senile dementia, and Alzheimer’s, Huntington’s and Parkinson’s diseases.

Also included in the launch is a comprehensive suite of serum steroid, thyroid, and peptide hormones, together with other factors that are key to hormone action and brain health. One of these is Vitamin B12, a key nutrient in which an estimated 20% of the population is deficient but which is vital to a variety of processes in the body. ZRT’s CEO and Founder, David Zava, PhD., announces, “we are intentionally launching BDNF alongside a comprehensive suite of tests for the purpose of deciphering if low BDNF is associated with suboptimal hormone levels and could be raised by correcting hormone imbalances.”

ZRT Laboratory’s mission is to give health care providers a more complete look at their patient’s health and allow for more robust treatment decisions to help curb aging of the brain and peripheral nervous system. When taken in the context of symptoms and clinical conditions, BDNF testing can play a key role in helping patients to modify lifestyle factors and suboptimal hormone levels that have been shown to negatively impact the body’s production of BDNF, and thereby improve the long-term health of their central and peripheral nervous systems to help slow brain aging.

To find out more about BDNF and other serum hormone tests provided by ZRT Laboratory, give ZRT’s customer service a call at 866.600.1636 or email

About ZRT Laboratory
ZRT Laboratory is a CLIA-certified commercial and research laboratory founded in 1998 by breast cancer researcher David Zava, Ph.D. ZRT has pioneered innovative testing methods for hormones, neurotransmitters, heavy metals and more, offering health care professionals convenient testing options in different body fluids including saliva, dried blood spot, dried urine, and serum. With over 10 million clinical tests performed over the past 20+ years, coupled with our signature personalized test report, ZRT Laboratory has become a world recognized leader in hormone and wellness testing. Individuals, health care providers in all 50 states and in over 100 countries, as well as research-oriented government, private, and academic organizations worldwide use our testing. Learn more at

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. Xybion Launches Preclinical Gold Standard Digital Laboratory Execution Solution for Laboratory Processes and Operations
2. National Laboratory Launches Partnership with Frederick CREST
3. GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu
4. Flagship's Digital Tissue Image Analysis Approach Validated in Assessment of Dystrophin Muscle Biopsies; Findings Published in Archives of Pathology & Laboratory Medicine
5. uBiome and Jackson Laboratory for Genomic Medicine to Study Pathogen Transmission in Geriatric Communities
6. OHAUS Introduces New Line of Laboratory Equipment for the Life Sciences
7. The World Laboratory Market is $108.5 Billion Market and Growing: Report
8. RURO Celebrates Decade of Laboratory Software Solutions
9. 11th Double Helix Medals raises $4.3 million for biomedical research and education at Cold Spring Harbor Laboratory
10. Dr. David Tuveson named Director, NCI-Designated Cancer Center at Cold Spring Harbor Laboratory
11. Opentrons Opens Up Biology Laboratory Automation Platform with New API
Post Your Comments:
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):